JPRN-UMIN000007948
Completed
Phase 2
Breast Cancer Study of Clinical Efficacy and Safty of Avastin with Paclitaxel in the 1st-taxane-line - BRAVE study
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hiroshima University
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Forbidden case to use paclitaxel and bevacizumab. (2\) With uncontrollable hypertension. (3\) Nonhealing wound. (4\) With VTE or PE. (5\) With GI perforation or Digestive ulcer. (6\) Severe cardiac disease (Ex. Congestive heart failure or coronary artery disease)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical performance study of breast cancer prognostic diagnosticsGenesWell™ BCT in Korean patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancerKCT0004263Samsung Medical Center500
Recruiting
Not Applicable
Verification of the effectiveness of breast cancer education for healthy peoplehealthy peopleJPRN-UMIN000046287Tokyo Medical and Dental Univ.300
Completed
Not Applicable
Research on the effectiveness and safety of microwave mammographyJPRN-UMIN000016922Graduate School of Science, Kobe University Kenjiro Kimura research group300
Recruiting
Phase 2
Research on the effectiveness and safety of microwave mammographyJPRN-jRCTs052180114kunihisa tomonari300
Recruiting
Not Applicable
Study on the efficacy and sfety of breast diagnostic imaging equipment (microwave scattered field tomographic imaging machine-a)brest cancerJPRN-UMIN000023928Kobe University40